Health sector Programme

The chapter is organized to demonstrate the close interconnections between industrial and health improvement in recent Ethiopian experience. After an overview of the stages of pharmaceutical industrial development in Ethiopia over the last 50 years, the chapter turns to an examination of the context and framework of Ethiopian health policies and the supply of medicines, describing the importance of medicines demand for the industry and industrial supply for health sector development. We describe how the health sector development programme is linked to the provision of essential medicines in the primary health care (PHC) system of the country, and the government s social responsibility in providing medicines to the population. 

Back in 2003, Brazil s and Mozambique s presidents, Luiz Inacio Lula da Silva and Joaquim Chissano, agreed to set up the first pharmaceutical factory in Mozambique, to be entirely owned by the national government. The project - widely known as the Brazil-Mozambican anti-retro-viral factory because of its commitment to produce AIDS drugs - still represents the single most expensive and eye-catching project of Brazil s South-South cooperation programme in the health sector. 

FMoH (2012) Health Sector Development Programmes 111, IV FMOH, Health Sector Development Programme Annual Performance Report 2011/12, available from http //www.moh.gov.et/documents/26765/28899/Annual+Perfor mance+Report+2011/3ba3483a-9ee0-4a8b-bc39-4caSacd8a9eb version=1.2 [accessed 3 May 2015]. 

Table 5.2 Public sector drug import value, by source and type of health programme (2012 US )...

Private Sector Innovation Programme for Health (2014). Overview of Experiences in the Pharmaceutical Supply Chain Implications of the Poor in Kenya. Available from http //www.psp4h.com/ [accessed 3 May 2015]. 

Catriona Manville is a senior analyst at RAND Europe where she works in innovation and technology policy. She works on and manages research, policy analysis and evaluation studies across the sectors of health and higher education for clients in a variety of sectors including public-private partnerships, public health, the pharmaceutical industry and higher education institutions. In particular she has been involved in studies evaluating programmes and interventions in sub-Saharan Africa. She holds a PhD in Biochemistry from Newcastle University. 

---